{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:40:40Z","timestamp":1793173240104,"version":"4.5.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study evaluated trends in population immunity against measles, rubella, mumps, and varicella in Suqian City (2005\u20132024) using serological surveys (2019\u20132024) and incidence data, incorporating participants with known\/unknown vaccination statuses to explore immunity dynamics amid evolving policies, and inform public health planning.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Serum samples from 541 (2019) and 506 (2024) healthy participants were analyzed for virus-specific IgG antibodies using ELISA. Disease incidence data were obtained from China\u2019s National Notifiable Disease Reporting System. Statistical analyses compared seroprevalence, geometric mean concentrations (GMCs), and incidence trends before and after policy adjustments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Optimized two-dose strategies significantly improved seropositivity rates for rubella (65.1% to 70.8%), mumps (77.6% to 85.8%), and varicella (76.9% to 79.5%), with corresponding GMC increases. Incidence declines were notable: varicella (183.3\/100,000 to 59.3\/100,000), rubella (2.8\/100,000 to 0.04\/100,000), and mumps (24.4\/100,000 to &amp;lt;5.0\/100,000). However, measles seropositivity declined from 85.9% to 79.3% (p&amp;lt;0.05). GMC analysis showed increases for rubella (31.5 to 42.2 IU\/ml), mumps (277.8 to 350.6 IU\/ml), and varicella (295.9 to 309.8 IU\/ml), but a decrease for measles (577.9 to 499.2 mIU\/ml, p&amp;lt;0.001). Preschool children (2\u20135 years) exhibited the highest immunity levels in 2024.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Population immunity against rubella, mumps, and varicella improved (2019\u20132024) with reduced incidence, while measles immunity declined, revealing vulnerabilities. Targeted strategies (e.g., catch-up campaigns for adolescents\/adults, optimized infant vaccination) are needed to strengthen protection, considering interactions of policies, public health measures, and demographics.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1630442","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T05:33:50Z","timestamp":1755149630000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of vaccination strategy adjustments on antibody levels against measles, rubella, mumps, and varicella in China: a single-center serological survey"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhixin","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-056013","article-title":"Impact of routine childhood immunization in reducing vaccine-preventable diseases in the United States","volume":"150","author":"Talbird","year":"2022","journal-title":"Pediatrics"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7246a3","article-title":"Progress toward measles elimination - worldwide, 2000-2022","volume":"72","author":"Minta","year":"2023","journal-title":"Mmwr Morb Mortal Wkly Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60419-5","article-title":"Mumps","volume":"371","author":"Hviid","year":"2008","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02691-X","article-title":"Rubella","volume":"399","author":"Winter","year":"2022","journal-title":"Lancet"},{"key":"B5","first-page":"95","article-title":"Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies","volume":"41","author":"Freer","year":"2018","journal-title":"New Microbiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107189","article-title":"Global resurgence of measles in the vaccination era and influencing factors","volume":"147","author":"Bidari","year":"2024","journal-title":"Int J Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2024.101238","article-title":"Measles matter: Recent outbreaks highlight the need for catch-up vaccination in Europe and around the globe","volume":"58","author":"Al-Tawfiq","year":"2024","journal-title":"New Microbes New Infect"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2021.2009128","article-title":"Impact of COVID-19 pandemic on routine immunization","volume":"53","author":"Ota","year":"2021","journal-title":"Ann Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16112","article-title":"Decline in child vaccination coverage during the COVID-19 pandemic - Michigan Care Improvement Registry, May 2016-May 2020","volume":"20","author":"Bramer","year":"2020","journal-title":"Am J Transplant"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(21)00512-X","article-title":"Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories","volume":"10","author":"Shet","year":"2022","journal-title":"Lancet Glob Health"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.46234\/ccdcw2025.094","article-title":"Vaccination status and incidences of measles, mumps, and rubella - worldwide, 2014-2023","volume":"7","author":"Liu","year":"2025","journal-title":"China Cdc Wkly"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12080842","article-title":"A serological survey of measles and rubella antibodies among different age groups in eastern China","volume":"12","author":"Yan","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1924522","article-title":"One single-center serological survey on measles, rubella and mumps antibody levels of people in Youyang, China","volume":"17","author":"Wang","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2114255","article-title":"Comparison of varicella outbreaks in schools in China during different vaccination periods","volume":"18","author":"Sun","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1472189","article-title":"Rubella antibody levels in the healthy Chinese population: a meta-analysis","volume":"15","author":"Zhuo","year":"2024","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.epidem.2022.100594","article-title":"Impact of vaccine effectiveness and coverage on preventing large mumps outbreaks on college campuses: Implications for vaccination strategy","volume":"40","author":"Melgar","year":"2022","journal-title":"Epidemics"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2017.1965","article-title":"Evaluation of combination measles-mumps-rubella-varicella vaccine introduction in Australia","volume":"171","author":"Macartney","year":"2017","journal-title":"JAMA Pediatr"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1956227","article-title":"Impact of non-pharmaceutical interventions on the incidences of vaccine-preventable diseases during the COVID-19 pandemic in the eastern of China","volume":"17","author":"Sun","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10101316","article-title":"Waning of maternal antibodies against measles suggests a large window of susceptibility in infants in lao people\u2019s democratic republic","volume":"10","author":"Khampanisong","year":"2021","journal-title":"Pathogens"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.19914\/j.cjvi.2014.03.001","article-title":"Measles epidemiology characteristics and progress toward measles elimination in China, 2012-2013","volume":"20","author":"Ma","year":"2014","journal-title":"Chin J Vaccines Immun"},{"key":"B22","doi-asserted-by":"publisher","first-page":"ofv6","DOI":"10.1093\/ofid\/ofv006","article-title":"Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009-2010","volume":"2","author":"Lebo","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1375151","article-title":"Immunity against measles, mumps, rubella, and varicella among homeless individuals in Germany - A nationwide multi-center cross-sectional study","volume":"12","author":"Graf","year":"2024","journal-title":"Front Public Health"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3180616c8f","article-title":"Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine","volume":"26","author":"Vesikari","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2023.2252065","article-title":"Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context","volume":"22","author":"Casabona","year":"2023","journal-title":"Expert Rev Vaccines"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2015.1057572","article-title":"Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials","volume":"14","author":"Leung","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"B27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1109\/TNB.2021.3136198","article-title":"Dynamic characterization of single cells based on temporal cellular mechanical properties","volume":"22","author":"Ma","year":"2023","journal-title":"IEEE Trans Nanobiosci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jpha.2023.03.002","article-title":"Quantitative characterization of cell physiological state based on dynamical cell mechanics for drug efficacy indication","volume":"13","author":"Ma","year":"2023","journal-title":"J Pharm Anal"},{"key":"B29","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12859-021-04364-5","article-title":"Concentration optimization of combinatorial drugs using Markov chain-based models","volume":"22","author":"Ma","year":"2021","journal-title":"BMC Bioinf"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1630442\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T05:33:51Z","timestamp":1755149631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1630442\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2025.1630442"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1630442","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"article-number":"1630442"}}